Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
19842.9k citationsJ L Cordell, Brunangelo Falini et al.Journal of Histochemistry & Cytochemistryprofile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
Countries citing papers authored by S.M. MacDonald
Since
Specialization
Citations
This map shows the geographic impact of S.M. MacDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.M. MacDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.M. MacDonald more than expected).
This network shows the impact of papers produced by S.M. MacDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.M. MacDonald. The network helps show where S.M. MacDonald may publish in the future.
Co-authorship network of co-authors of S.M. MacDonald
This figure shows the co-authorship network connecting the top 25 collaborators of S.M. MacDonald.
A scholar is included among the top collaborators of S.M. MacDonald based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S.M. MacDonald. S.M. MacDonald is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Pulford, Karen, Elisabeth Ralfkiær, S.M. MacDonald, et al.. (1986). A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes.. PubMed. 57(1). 71–6.63 indexed citations
MacDonald, S.M., Karen Pulford, Brunangelo Falini, Kingsley Micklem, & D Y Mason. (1986). A monoclonal antibody recognizing the p150/95 leucocyte differentiation antigen.. PubMed. 59(3). 427–31.30 indexed citations
6.
Hogg, Nancy, S.M. MacDonald, M. Slusarenko, & Peter C. L. Beverley. (1984). Monoclonal antibodies specific for human monocytes, granulocytes and endothelium.. PubMed. 53(4). 753–67.149 indexed citations
7.
Cordell, J L, Brunangelo Falini, Wendy N. Erber, et al.. (1984). Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).. Journal of Histochemistry & Cytochemistry. 32(2). 219–229.2899 indexed citations breakdown →
8.
MacDonald, S.M., et al.. (1982). Immunological parameters in the aged and in Alzheimer's disease.. PubMed. 49(1). 123–8.29 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.